vs

Side-by-side financial comparison of NU SKIN ENTERPRISES, INC. (NUS) and PROCORE TECHNOLOGIES, INC. (PCOR). Click either name above to swap in a different company.

NU SKIN ENTERPRISES, INC. is the larger business by last-quarter revenue ($370.3M vs $349.1M, roughly 1.1× PROCORE TECHNOLOGIES, INC.). NU SKIN ENTERPRISES, INC. runs the higher net margin — 3.9% vs -10.8%, a 14.7% gap on every dollar of revenue. On growth, PROCORE TECHNOLOGIES, INC. posted the faster year-over-year revenue change (15.6% vs -16.9%). PROCORE TECHNOLOGIES, INC. produced more free cash flow last quarter ($109.2M vs $5.9M). Over the past eight quarters, PROCORE TECHNOLOGIES, INC.'s revenue compounded faster (13.8% CAGR vs -5.8%).

Nu Skin Enterprises, Inc. is an American multilevel marketing company that develops and sells personal care products and dietary and nutritional supplements. Under the Nu Skin and Pharmanex brands, the company sells its products in 54 markets through a network of approximately 1.2 million independent distributors.

Procore Technologies is an American construction management software as a service company founded in 2002, with headquarters in Carpinteria, California. Procore hosts a platform to connect those involved in the construction industry on a global platform. The software allows for the creation of simplified workflows and displays a consolidated view of construction products that includes the tracking of tasks, management of project workflows, and scheduling.

NUS vs PCOR — Head-to-Head

Bigger by revenue
NUS
NUS
1.1× larger
NUS
$370.3M
$349.1M
PCOR
Growing faster (revenue YoY)
PCOR
PCOR
+32.5% gap
PCOR
15.6%
-16.9%
NUS
Higher net margin
NUS
NUS
14.7% more per $
NUS
3.9%
-10.8%
PCOR
More free cash flow
PCOR
PCOR
$103.4M more FCF
PCOR
$109.2M
$5.9M
NUS
Faster 2-yr revenue CAGR
PCOR
PCOR
Annualised
PCOR
13.8%
-5.8%
NUS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NUS
NUS
PCOR
PCOR
Revenue
$370.3M
$349.1M
Net Profit
$14.5M
$-37.6M
Gross Margin
70.7%
80.1%
Operating Margin
6.3%
-12.3%
Net Margin
3.9%
-10.8%
Revenue YoY
-16.9%
15.6%
Net Profit YoY
140.1%
39.6%
EPS (diluted)
$0.27
$-0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NUS
NUS
PCOR
PCOR
Q4 25
$370.3M
$349.1M
Q3 25
$364.2M
$338.9M
Q2 25
$386.1M
$323.9M
Q1 25
$364.5M
$310.6M
Q4 24
$445.6M
$302.0M
Q3 24
$430.1M
$295.9M
Q2 24
$439.1M
$284.3M
Q1 24
$417.3M
$269.4M
Net Profit
NUS
NUS
PCOR
PCOR
Q4 25
$14.5M
$-37.6M
Q3 25
$17.1M
$-9.1M
Q2 25
$21.1M
$-21.1M
Q1 25
$107.5M
$-33.0M
Q4 24
$-36.1M
$-62.3M
Q3 24
$8.3M
$-26.4M
Q2 24
$-118.3M
$-6.3M
Q1 24
$-533.0K
$-11.0M
Gross Margin
NUS
NUS
PCOR
PCOR
Q4 25
70.7%
80.1%
Q3 25
70.5%
79.7%
Q2 25
68.8%
79.1%
Q1 25
67.8%
79.1%
Q4 24
62.7%
81.2%
Q3 24
70.1%
81.4%
Q2 24
70.0%
83.1%
Q1 24
70.5%
83.0%
Operating Margin
NUS
NUS
PCOR
PCOR
Q4 25
6.3%
-12.3%
Q3 25
5.9%
-4.4%
Q2 25
8.0%
-9.3%
Q1 25
-2.7%
-11.7%
Q4 24
-11.9%
-21.9%
Q3 24
4.2%
-12.3%
Q2 24
-28.6%
-5.2%
Q1 24
2.1%
-7.0%
Net Margin
NUS
NUS
PCOR
PCOR
Q4 25
3.9%
-10.8%
Q3 25
4.7%
-2.7%
Q2 25
5.5%
-6.5%
Q1 25
29.5%
-10.6%
Q4 24
-8.1%
-20.6%
Q3 24
1.9%
-8.9%
Q2 24
-26.9%
-2.2%
Q1 24
-0.1%
-4.1%
EPS (diluted)
NUS
NUS
PCOR
PCOR
Q4 25
$0.27
$-0.25
Q3 25
$0.34
$-0.06
Q2 25
$0.43
$-0.14
Q1 25
$2.14
$-0.22
Q4 24
$-0.73
$-0.42
Q3 24
$0.17
$-0.18
Q2 24
$-2.38
$-0.04
Q1 24
$-0.01
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NUS
NUS
PCOR
PCOR
Cash + ST InvestmentsLiquidity on hand
$239.8M
$768.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$805.2M
$1.3B
Total Assets
$1.4B
$2.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NUS
NUS
PCOR
PCOR
Q4 25
$239.8M
$768.5M
Q3 25
$253.0M
$684.0M
Q2 25
$265.4M
$620.9M
Q1 25
$213.6M
$566.7M
Q4 24
$198.0M
$775.4M
Q3 24
$237.8M
$756.9M
Q2 24
$232.9M
$735.4M
Q1 24
$221.2M
$744.6M
Stockholders' Equity
NUS
NUS
PCOR
PCOR
Q4 25
$805.2M
$1.3B
Q3 25
$799.8M
$1.2B
Q2 25
$787.8M
$1.2B
Q1 25
$754.0M
$1.2B
Q4 24
$651.5M
$1.3B
Q3 24
$706.9M
$1.3B
Q2 24
$686.2M
$1.3B
Q1 24
$810.2M
$1.2B
Total Assets
NUS
NUS
PCOR
PCOR
Q4 25
$1.4B
$2.2B
Q3 25
$1.4B
$2.1B
Q2 25
$1.4B
$2.0B
Q1 25
$1.4B
$1.9B
Q4 24
$1.5B
$2.1B
Q3 24
$1.6B
$2.0B
Q2 24
$1.6B
$2.0B
Q1 24
$1.7B
$1.9B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NUS
NUS
PCOR
PCOR
Operating Cash FlowLast quarter
$16.6M
$114.9M
Free Cash FlowOCF − Capex
$5.9M
$109.2M
FCF MarginFCF / Revenue
1.6%
31.3%
Capex IntensityCapex / Revenue
2.9%
1.6%
Cash ConversionOCF / Net Profit
1.15×
TTM Free Cash FlowTrailing 4 quarters
$46.0M
$282.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NUS
NUS
PCOR
PCOR
Q4 25
$16.6M
$114.9M
Q3 25
$27.5M
$88.5M
Q2 25
$35.8M
$30.8M
Q1 25
$389.0K
$66.0M
Q4 24
$25.8M
$29.1M
Q3 24
$31.4M
$39.3M
Q2 24
$51.2M
$58.7M
Q1 24
$3.3M
$69.1M
Free Cash Flow
NUS
NUS
PCOR
PCOR
Q4 25
$5.9M
$109.2M
Q3 25
$17.6M
$83.1M
Q2 25
$35.8M
$27.9M
Q1 25
$-13.2M
$62.0M
Q4 24
$13.2M
$17.4M
Q3 24
$22.8M
$35.7M
Q2 24
$43.1M
$56.8M
Q1 24
$-9.0M
$67.1M
FCF Margin
NUS
NUS
PCOR
PCOR
Q4 25
1.6%
31.3%
Q3 25
4.8%
24.5%
Q2 25
9.3%
8.6%
Q1 25
-3.6%
20.0%
Q4 24
3.0%
5.8%
Q3 24
5.3%
12.1%
Q2 24
9.8%
20.0%
Q1 24
-2.1%
24.9%
Capex Intensity
NUS
NUS
PCOR
PCOR
Q4 25
2.9%
1.6%
Q3 25
2.7%
1.6%
Q2 25
0.0%
0.9%
Q1 25
3.7%
1.3%
Q4 24
2.8%
3.9%
Q3 24
2.0%
1.2%
Q2 24
1.9%
0.7%
Q1 24
2.9%
0.8%
Cash Conversion
NUS
NUS
PCOR
PCOR
Q4 25
1.15×
Q3 25
1.61×
Q2 25
1.69×
Q1 25
0.00×
Q4 24
Q3 24
3.79×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NUS
NUS

Other$161.9M44%
Mainland China Segment$52.0M14%
Southeast Asia Pacific Segment$50.5M14%
Europe And Africa Segment$41.8M11%
Hong Kong Taiwan Segment$29.6M8%
South Korea Segment$28.4M8%
Rhyz Other Segment$6.1M2%

PCOR
PCOR

US$298.3M85%
Non Us$50.9M15%

Related Comparisons